BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33107524)

  • 1. Sn(IV)
    Babu B; Mack J; Nyokong T
    Dalton Trans; 2020 Nov; 49(43):15180-15183. PubMed ID: 33107524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The photodynamic activity properties of a series of structurally analogous tetraarylporphyrin, chlorin and N-confused porphyrin dyes and their Sn(IV) complexes.
    Soy R; Babu B; Mack J; Nyokong T
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103815. PubMed ID: 37777078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An octabrominated Sn(iv) tetraisopropylporphyrin as a photosensitizer dye for singlet oxygen biomedical applications.
    Babu B; Mack J; Nyokong T
    Dalton Trans; 2020 Jul; 49(28):9568-9573. PubMed ID: 32578634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diketopyrrolopyrrole-porphyrin conjugates with high two-photon absorption and singlet oxygen generation for two-photon photodynamic therapy.
    Schmitt J; Heitz V; Sour A; Bolze F; Ftouni H; Nicoud JF; Flamigni L; Ventura B
    Angew Chem Int Ed Engl; 2015 Jan; 54(1):169-73. PubMed ID: 25370127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic activity of Sn(IV) tetrathien-2-ylchlorin against MCF-7 breast cancer cells.
    Babu B; Mack J; Nyokong T
    Dalton Trans; 2021 Feb; 50(6):2177-2182. PubMed ID: 33496304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-photon photodynamic therapy.
    Bhawalkar JD; Kumar ND; Zhao CF; Prasad PN
    J Clin Laser Med Surg; 1997; 15(5):201-4. PubMed ID: 9612170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Photodynamic Anticancer and Antibacterial Activity Properties of a Series of
    Soy R; Babu B; Mack J; Nyokong T
    Molecules; 2023 May; 28(10):. PubMed ID: 37241769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meso-tetrakis(p-sulfonatophenyl)N-confused porphyrin tetrasodium salt: a potential sensitizer for photodynamic therapy.
    Thomas AP; Saneesh Babu PS; Asha Nair S; Ramakrishnan S; Ramaiah D; Chandrashekar TK; Srinivasan A; Radhakrishna Pillai M
    J Med Chem; 2012 Jun; 55(11):5110-20. PubMed ID: 22582931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracationic porphyrin derivatives against human breast cancer.
    Gamelas SRD; Moura NMM; Habraken Y; Piette J; Neves MGPMS; Faustino MAF
    J Photochem Photobiol B; 2021 Sep; 222():112258. PubMed ID: 34399205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble green perylenediimide (PDI) dyes as potential sensitizers for photodynamic therapy.
    Yukruk F; Dogan AL; Canpinar H; Guc D; Akkaya EU
    Org Lett; 2005 Jul; 7(14):2885-7. PubMed ID: 15987161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazole-modified porphyrin as a pH-responsive sensitizer for cancer photodynamic therapy.
    Zhu X; Lu W; Zhang Y; Reed A; Newton B; Fan Z; Yu H; Ray PC; Gao R
    Chem Commun (Camb); 2011 Oct; 47(37):10311-3. PubMed ID: 21853198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photophysical characterization and in vitro anti-leishmanial effect of 5,10,15,20-tetrakis(4-fluorophenyl) porphyrin and the metal (Zn(II), Sn(IV), Mn(III) and V(IV)) derivatives.
    Espitia-Almeida F; Díaz-Uribe C; Vallejo W; Gómez-Camargo D; Bohórquez ARR; Zarate X; Schott E
    Biometals; 2022 Feb; 35(1):159-171. PubMed ID: 34993713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current clinical and preclinical photosensitizers for use in photodynamic therapy.
    Detty MR; Gibson SL; Wagner SJ
    J Med Chem; 2004 Jul; 47(16):3897-915. PubMed ID: 15267226
    [No Abstract]   [Full Text] [Related]  

  • 14. Activatable photodynamic destruction of cancer cells by NIR dye/photosensitizer loaded liposomes.
    Yuan A; Tang X; Qiu X; Jiang K; Wu J; Hu Y
    Chem Commun (Camb); 2015 Feb; 51(16):3340-2. PubMed ID: 25619336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blue-Light-Activated Water-Soluble Sn(IV)-Porphyrins for Antibacterial Photodynamic Therapy (aPDT) against Drug-Resistant Bacterial Pathogens.
    Nagarajan T; Gayathri MP; Mack J; Nyokong T; Govindarajan S; Babu B
    Mol Pharm; 2024 May; 21(5):2365-2374. PubMed ID: 38620059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Theranostic Agent Combining a Two-Photon-Absorbing Photosensitizer for Photodynamic Therapy and a Gadolinium(III) Complex for MRI Detection.
    Schmitt J; Heitz V; Sour A; Bolze F; Kessler P; Flamigni L; Ventura B; Bonnet CS; Tóth É
    Chemistry; 2016 Feb; 22(8):2775-86. PubMed ID: 26791109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photophysical Characterization and in Vitro Phototoxicity Evaluation of 5,10,15,20-Tetra(quinolin-2-yl)porphyrin as a Potential Sensitizer for Photodynamic Therapy.
    Costa LD; e Silva Jde A; Fonseca SM; Arranja CT; Urbano AM; Sobral AJ
    Molecules; 2016 Mar; 21(4):439. PubMed ID: 27043519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy.
    Li MY; Mi L; Meerovich G; Soe TW; Chen T; Than NN; Yan YJ; Chen ZL
    J Cancer Res Clin Oncol; 2022 Sep; 148(9):2335-2346. PubMed ID: 35522290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyrins containing basic aliphatic amino groups as potential broad-spectrum antimicrobial agents.
    Scanone AC; Gsponer NS; Alvarez MG; Durantini EN
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():220-227. PubMed ID: 30278279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New porphyrin photosensitizers-Synthesis, singlet oxygen yield, photophysical properties and application in PDT.
    Wang X; Lv H; Sun Y; Zu G; Zhang X; Song Y; Zhao F; Wang J
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Oct; 279():121447. PubMed ID: 35689847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.